Literature DB >> 5910936

The effects of glucagon on systemic and hepatosplanchnic haemodynamics and on net peripheral and hepatosplanchnic balance of glucose, lactic and pyruvic acids in normal subjects and cirrhotics.

F S Feruglio, F Greco, L Cesano, P G Colongo, G Sardi, L Chiandussi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5910936

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  7 in total

1.  Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs.

Authors:  M Kogire; K Inoue; S Sumi; R Doi; M Yun; H Kaji; T Tobe
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

2.  Comparison of the effects of intravenous and intrasplenic infusions of glucagon on cardiac output and its distribution in the rat.

Authors:  A J Nichols; C R Hiley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

3.  Hemodynamic responses to glucagon: an experimental study of central, visceral and peripheral effects.

Authors:  N G Kock; S Tibblin; W G Schenk
Journal:  Ann Surg       Date:  1970-03       Impact factor: 12.969

4.  Effect of glucagon on protein synthesis in human rectal cancer in situ.

Authors:  W H Hartl; H Demmelmair; K W Jauch; B Koletzko; F W Schildberg
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

5.  Effect of glucagon and blood transfusion on liver metabolism in hemorrhagic shock.

Authors:  B Lindberg; H Haljamäe; O Jonsson; S Pettersson
Journal:  Ann Surg       Date:  1978-02       Impact factor: 12.969

6.  Glycerol clearance in alcoholic liver disease.

Authors:  D G Johnston; K G Alberti; R Wright; P G Blain
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

7.  In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.

Authors:  N Barzilai; P Cohen; E Karnieli; R Enat; O Epstein; J Owen; N McIntyre
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.